Evaluation of prognostic factors and survival rates in malignant feline mammary gland neoplasms
Nenhuma Miniatura disponível
Data
2015-10-12
Autores
Campos, Cecilia B. de[UNESP]
Damasceno, Karine A.
Gamba, Conrado O.
Ribeiro, Ana M.
Machado, Carla J.
Lavalle, Gleidice E.
Cassali, Geovanni D.
Título da Revista
ISSN da Revista
Título de Volume
Editor
SAGE Publications
Resumo
To investigate the association of prognostic factors of feline mammary gland neoplasms, correlating them with overall survival (OS). Fifty-six primary malignant mammary gland neoplasms and 16 metastatic lymph nodes from 37 female cats were analyzed. Clinical staging, histologic type and grade, and immunohistochemistry for Ki-67, progesterone and estrogen receptor, human epidermal growth factor receptor type 2 (HER-2), cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) were evaluated. Follow-up was performed in order to correlate prognostic factors with OS. Lymph node metastasis was found in 35% of cases. Clinical stage III, tubulopapillary carcinomas and histologic grade II cases prevailed in the study. Most neoplasms were positive for hormonal receptors, negative for HER-2 overexpression and presented VEGF overexpression. Immunoreactivity for Ki-67 (P = 0.046) and COX-2 (P = 0.007) was higher in metastases than in primary tumors. COX-2 (P = 0.089), HER-2 (P = 0.012) and histologic grade (P = 0.080) were correlated with OS. The data suggest that inhibition of ovarian hormones and COX-2 may represent a therapeutic option for malignant feline mammary gland neoplasms. COX-2 scores and Ki-67 index should be analyzed in primary tumors and metastases, and histologic grade, HER-2 status and COX-2 scores had a direct influence in OS. Prognostic factors allow for a better understanding of disease outcome in a condition that is characterized by a poor prognosis. The present work highlights the need for further studies on endocrine therapy and COX-2 inhibitors, which could influence OS.
Descrição
Palavras-chave
Como citar
Journal Of Feline Medicine And Surgery, p. 1-10, 2015.